文章：

胰腺癌健康差异：药理学人类学视角

Pancreatic Cancer Health Disparity: Pharmacologic Anthropology

原文发布日期：20 October 2023

DOI: 10.3390/cancers15205070

类型: Article

开放获取: 是

英文摘要：

Pancreatic cancer (PCa) remains a formidable global health challenge, with high mortality rates and limited treatment options. While advancements in pharmacology have led to improved outcomes for various cancers, PCa continues to exhibit significant health disparities, disproportionately affecting certain populations. This paper explores the intersection of pharmacology and anthropology in understanding the health disparities associated with PCa. By considering the socio-cultural, economic, and behavioral factors that influence the development, diagnosis, treatment, and outcomes of PCa, pharmacologic anthropology provides a comprehensive framework to address these disparities and improve patient care.

摘要翻译： 

胰腺癌（PCa）依然是全球健康领域面临的严峻挑战，其死亡率高且治疗选择有限。尽管药理学进展已推动多种癌症治疗效果的提升，但胰腺癌仍表现出显著的健康差异，对特定人群的影响尤为突出。本文探讨了药理学与人类学在理解胰腺癌相关健康差异中的交叉点。通过考察影响胰腺癌发生、诊断、治疗及预后的社会文化、经济与行为因素，药理人类学为应对这些差异并改善患者护理提供了一个综合性分析框架。

原文链接：

Pancreatic Cancer Health Disparity: Pharmacologic Anthropology